Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Xiu Li Guo"'
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
ObjectivePerirenal adipose tissue (PAT) has emerged as a potential therapeutic target for cardiovascular disease (CVD). However, the relationship between increased perirenal fat thickness (PrFT) and CVD risks in individuals with type 2 diabetes melli
Externí odkaz:
https://doaj.org/article/b055a6d7536c4ea4bef6ee394497581f
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundLimited research has been conducted to quantitatively assess the impact of systemic inflammation in metabolic dysfunction-associated fatty liver disease (MAFLD) and sub-clinical carotid atherosclerosis (SCAS). The systemic immune-inflammati
Externí odkaz:
https://doaj.org/article/26252ec2724d46139e507627ea037d9a
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
ObjectiveEmerging evidence highlighted that perirenal adipose tissue might regulate the cardiovascular and metabolism system through several pathways. This study aimed to assess the association between perirenal fat thickness (PrFT) and subclinical c
Externí odkaz:
https://doaj.org/article/1c011ee83a8b4709a6b96997ba161968
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
ObjectiveDisturbances in high-density lipoprotein cholesterol (HDL-c) metabolic pathways can affect bone metabolism, which may rely on the particle function of apolipoprotein rather than HDL-c levels. This study aimed to evaluate the correlation of s
Externí odkaz:
https://doaj.org/article/f4d768bf3f6f45b59b2e2bc01de3a616
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
ObjectivesEmerging evidence demonstrated that perirenal fat may modulate bone metabolism through several pathological pathways. This study was aimed to assess the associations between perirenal fat thickness (PrFT) and bone turnover markers (BTMs) an
Externí odkaz:
https://doaj.org/article/00dbb993578f4252b4356f398e637f97
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
ObjectiveIncreasing evidence highlighted that chronic inflammation involved in the development of metabolic syndrome (MetS) and Type 2 diabetes mellitus (T2DM). This prospective study was aimed to assess the association between MetS and novel pro-inf
Externí odkaz:
https://doaj.org/article/86e9ea8ae749474481c8556d4f57e462
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
ObjectiveIncreasing evidence suggested that perirenal fat thickness (PrFT) was associated with metabolic risk factors. This study aimed to assess the association between PrFT and metabolic syndrome (MetS) in Chinese newly diagnosed type 2 diabetes (T
Externí odkaz:
https://doaj.org/article/ad6d385b43d942d289b52c63a3aa00b4
Autor:
Chao Sun, Lei Wang, Dan-dan Du, Jian-bo Ji, Xiao-xia Yang, Bing-fang Yu, Peng-fei Shang, Xiu-Li Guo
Publikováno v:
Oxidative Medicine and Cellular Longevity. 2022:1-19
Downregulated DSC2 involved in the metastasis of cancers. Unfortunately, its role on the development of gastric cancer (GC) and the potential mechanisms remain unclear. Bioinformatics analysis, Western blot, qRT-PCR, and immunohistochemistry were per
Autor:
Jin Qiuyang, Xiu-Li Guo, Jing Liao, Lei Wang, Jianbo Ji, Bingfang Yu, Xiaoxia Yang, Pengfei Shang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 9, Pp 2819-2834 (2021)
Resistance to breast cancer (BCa) chemotherapy severely hampers the patient's prognosis. MicroRNAs provide a potential therapeutic prospect for BCa. In this study, the reversal function of microRNA34a (miR34a) on doxorubicin (Dox) resistance of BCa a
Autor:
Jinxin Zhao, Xiao Zhu, Songwen Tan, Chuanpin Chen, Amal Kaddoumi, Xiu-Li Guo, Yu-Wei Lin, S. Y. Amy Cheung
Publikováno v:
Frontiers in pharmacology. 13